According to Sumitomo Pharma 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0.426269. At the end of 2023 the company had a P/S ratio of 0.5618.
Year | P/S ratio | Change |
---|---|---|
2023 | 0.5618 | -16.71% |
2022 | 0.6745 | -27.18% |
2021 | 0.9261 | -22.53% |
2020 | 1.20 | -33.78% |
2019 | 1.81 | -41.53% |
2018 | 3.09 | 115.28% |
2017 | 1.43 | -21.91% |
2016 | 1.84 | 27.87% |
2015 | 1.44 | 30.6% |
2014 | 1.10 | -35.45% |
2013 | 1.70 | 54.83% |
2012 | 1.10 | 12.28% |
2011 | 0.9802 | 17.36% |
2010 | 0.8352 | -43.57% |
2009 | 1.48 |